The store will not work correctly when cookies are disabled.
6-(4-(Methylthio)phenyl)-2-phenylimidazo[1,2-a]pyridine
ID: ALA4526691
PubChem CID: 155544102
Max Phase: Preclinical
Molecular Formula: C20H16N2S
Molecular Weight: 316.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CSc1ccc(-c2ccc3nc(-c4ccccc4)cn3c2)cc1
Standard InChI: InChI=1S/C20H16N2S/c1-23-18-10-7-15(8-11-18)17-9-12-20-21-19(14-22(20)13-17)16-5-3-2-4-6-16/h2-14H,1H3
Standard InChI Key: QNHYYRIWHXMPCR-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
32.2570 -2.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2559 -2.8377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9639 -3.2467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6736 -2.8372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6707 -2.0146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9621 -1.6093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3784 -3.2440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3783 -4.0623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0859 -4.4697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0819 -2.8348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7900 -3.2385 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7970 -4.0570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5776 -4.3033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.0531 -3.6370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5663 -2.9790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8690 -3.6282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2830 -4.3340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0994 -4.3274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5027 -3.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0837 -2.9092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2687 -2.9193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5492 -1.6098 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.5490 -0.7926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 12 1 0
11 10 1 0
10 7 2 0
4 7 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 11 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
14 16 1 0
1 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 316.43 | Molecular Weight (Monoisotopic): 316.1034 | AlogP: 5.39 | #Rotatable Bonds: 3 |
Polar Surface Area: 17.30 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 5.40 | CX LogP: 5.07 | CX LogD: 5.06 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.47 | Np Likeness Score: -1.66 |
References
1. Quattrini L, Gelardi ELM, Coviello V, Sartini S, Ferraris DM, Mori M, Nakano I, Garavaglia S, La Motta C.. (2020) Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells., 63 (9): [PMID:32223240] [10.1021/acs.jmedchem.9b01910] |